ICCC's logo.
Ticker Symbol: ICCC

Immucell Corp.

$9.10 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000811641

Company Profile

ImmuCell Corporation's purpose is to create scientifically proven and practical products that improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets First Defense®, providing Immediate Immunity™ to newborn dairy and beef calves, and is in the late stages of developing Re-Tain™, a novel treatment for subclinical mastitis without a milk discard requirement that provides an alternative to traditional antibiotics.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2835
Address: 56 Evergreen Dr
CEO: Michael Brigham
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $5.25
Change: $0.01 ( 0.29%)
Days Range: $5.05 - $5.35
Beta: -
52wk. High: $8.60
52wk. Low: $4.26
Ytd. Change -13.81%
50 Day Moving Average: $5.09
200 Day Moving Average: $5.09
Shares Outstanding: 7746864

Valuation

Market Cap: 4.1B
PE Ratio: -6.75
EPS (TTM): -0.778

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A